A nurse is reinforcing teaching with a client who has a new prescription for a nicotine transdermal system. Which of the following statements should the nurse make?
Explanation & Rationale
Choice A reason: A decrease in appetite is not a typical effect of starting a nicotine transdermal system. In fact, individuals may experience an increase in appetite and potential weight gain after quitting smoking, as nicotine acts as an appetite suppressant. It is important for clients to be aware of this potential change so they can plan healthy eating habits and manage their weight effectively. Choice B reason: Nicotine replacement therapy, including the nicotine transdermal system, is designed to help minimize symptoms of nicotine withdrawal. These symptoms can include cravings, irritability, anxiety, and difficulty concentrating. By providing a controlled release of nicotine, the transdermal system helps reduce the intensity of withdrawal symptoms and supports the quitting process. Choice C reason: It is unrealistic to expect clients to stop smoking immediately after starting a nicotine transdermal system. The goal of nicotine replacement therapy is to gradually reduce dependence on nicotine while managing withdrawal symptoms. Clients are often encouraged to set a quit date and use the transdermal system as part of a comprehensive plan to stop smoking over time. Choice D reason: Applying a new patch every 4 hours is incorrect and impractical. Nicotine transdermal patches are typically designed to be worn for 16 to 24 hours, depending on the specific product. Clients should follow the manufacturer's instructions and their healthcare provider's guidance for the proper use of the patch, usually replacing it once a day.